ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Daiichi Sankyo Co Ltd (PK)

Daiichi Sankyo Co Ltd (PK) (DSKYF)

36.94
0.65
(1.79%)
Closed September 20 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
36.94
Bid
33.70
Ask
37.10
Volume
916
33.86 Day's Range 37.10
23.45 52 Week Range 44.64
Market Cap
Previous Close
36.29
Open
33.86
Last Trade
19
@
33.86
Last Trade Time
Financial Volume
$ 32,897
VWAP
35.9133
Average Volume (3m)
2,749
Shares Outstanding
1,916,787,029
Dividend Yield
13,630.20%
PE Ratio
0.35
Earnings Per Share (EPS)
104.72
Revenue
1.63T
Net Profit
200.73B

About Daiichi Sankyo Co Ltd (PK)

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Biolog/vaccines
Headquarters
Chuo, Tokyo, Jpn
Founded
2005
Daiichi Sankyo Co Ltd (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker DSKYF. The last closing price for Daiichi Sankyo (PK) was $36.29. Over the last year, Daiichi Sankyo (PK) shares have traded in a share price range of $ 23.45 to $ 44.64.

Daiichi Sankyo (PK) currently has 1,916,787,029 shares outstanding. The market capitalization of Daiichi Sankyo (PK) is $69.56 billion. Daiichi Sankyo (PK) has a price to earnings ratio (PE ratio) of 0.35.

DSKYF Latest News

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular ...

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention of Recurrent...

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge PR Newswire PARSIPPANY, N.J., April 1, 2015 PARSIPPANY, N.J., April 1, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc., the US subsidiary of...

Venue Change

Tue, Oct 08, 2013 12:00 - Daiichi Sankyo Co., Ltd. (DSKYF: OTC Link) - Venue Change - The symbol, DSKYF, no longer trades on Grey Market. As of Tue, Oct 08, 2013, DSKYF trades on OTC Link. You...

Glaxo Files for Two Flu Vaccines - Analyst Blog

Recently, GlaxoSmithKline (GSK) announced that it has filed marketing applications for two influenza vaccines. The vaccines, up for approval, include a quadrivalent influenza vaccine for the...

Glaxo and Daiichi to Set Up JV - Analyst Blog

British drugmaker GlaxoSmithKline (GSK) recently announced that it has signed an agreement with Daiichi Sankyo (DSKYF) to form a joint venture (JV). The JV will be called Japan Vaccine Co., Ltd...

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources PR Newswire PARSIPPANY, N.J., June 28, 2011 PARSIPPANY, N.J., June 28, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc...

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc.

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc. PR Newswire PARSIPPANY, N.J., April 4, 2011 PARSIPPANY, N.J., April 4, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc. (DSI) announced...

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fib

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest...

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillatio

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest Clinical...

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology PR Newswire WOBURN, Massachusetts, October 12, 2010 WOBURN, Massachusetts, October 12, 2010 /PRNewswire/ -- ArQule, Inc...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.6-1.5982951518437.5438.4532.81634337.24323806CS
4-5.97-13.912840829642.9144.6432.81306338.81595397CS
121.253.502381619535.6944.6432.81274937.8856541CS
265.0515.835685167831.8944.6428.221564732.12582533CS
529.7435.808823529427.244.6423.451033931.26151939CS
15611.1743.344974776925.7744.6419.45794730.04597979CS
260-29.1772-44.129515466566.117295.9617.61637930.89752239CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JUVAFJuva Life Inc (CE)
$ 0.002
(199,900.00%)
15.5k
BLSTFBlackstone Minerals Ltd (PK)
$ 0.0271
(27,000.00%)
30k
TLSSTransportation and Logistics Systems Inc (CE)
$ 0.0001
(9,900.00%)
3.1M
GOSYGeckosystems International Corp (CE)
$ 0.0001
(9,900.00%)
1.15M
MMEXMMEX Resources Corporation (PK)
$ 0.0001
(9,900.00%)
745.41k
TEVNFTevano Systems Holdings Inc (CE)
$ 0.000001
(-99.99%)
10k
SNSTSunset Capital Assets Omc (CE)
$ 0.000001
(-99.99%)
85.03k
PNDDFPender Growth Fund Inc (PK)
$ 0.0012
(-99.98%)
100
HLLPFHello Pal International Inc (CE)
$ 0.000001
(-99.90%)
5k
ELOXEloxx Pharmaceuticals Inc (CE)
$ 0.000001
(-99.83%)
297
IMTLImage Protect Inc (PK)
$ 0.0002
(100.00%)
591.38M
TMGIMarquie Group Inc (PK)
$ 0.0001
(0.00%)
244.01M
SINCSincerity Applied Materials Holdings Corporation (PK)
$ 0.001
(42.86%)
214.48M
SIRCSolar Integrated Roofing Corporation (PK)
$ 0.0002
(0.00%)
167.08M
HMBLHUMBL Inc (PK)
$ 0.0001
(-33.33%)
118.85M

Your Recent History

Delayed Upgrade Clock